Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Noguchi
Akt Kinase-Interacting Protein1, a Novel Therapeutic Target for Lung Cancer With EGFR-activating and Gatekeeper Mutations
Oncogene
Cancer Research
Genetics
Molecular Biology
Jun Dimerization Protein 2 Is a Critical Component of the Nrf2/MafK Complex Regulating the Response to ROS Homeostasis
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Related publications
Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer With Activating EGFR Mutations
OncoTargets and Therapy
Oncology
Pharmacology
EGFR Kinase Domain Mutations – Functional Impact and Relevance for Lung Cancer Therapy
Oncogene
Cancer Research
Genetics
Molecular Biology
DDX49 Is a Novel Biomarker and Therapeutic Target for Lung Cancer Metastases
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer
Cancer Research
Cancer Research
Oncology
Cotargeting EGFR and Autophagy Signaling: A Novel Therapeutic Strategy for Non-Small-Cell Lung Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Allosterically Targeting EGFR Drug-Resistance Gatekeeper Mutations
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations
Cancer Discovery
Oncology
Influence of EGFR-activating Mutations on Sensitivity to Tyrosine Kinase Inhibitors in a KRAS Mutant Non-Small Cell Lung Cancer Cell Line
PLoS ONE
Multidisciplinary
OA 05.03 Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients With EGFR Activating and T790M Mutations
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary